Literature DB >> 10917581

Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease.

S J Inder1, Y V Bobryshev, S M Cherian, R S Lord, K Masuda, C Yutani.   

Abstract

The aim of this study was to analyze the cellular composition of the arterial wall in Takayasu's disease and to investigate the contribution of the various cell types to the immunoinflammatory processes and degenerative alterations of the vessel wall in this disease. Specimens of aorta were obtained at operation from 10 patients with Takayasu's arteritis. The duration of disease ranged from 2 months to 13 years. Immunohistochemical investigation was carried out using the antibodies CD3 (to identify T-cells), CD20 (B-cells), S-100 (dendritic cells), CD68 (macrophages), CD15 (granulocytes), von Willebrand factor (endothelial cells), and alpha-smooth muscle actin (smooth muscle cells). All specimens showed distinctive histologic features of Takayasu's arteritis and contained inflammatory infiltrates, but the degree of their accumulation within the aortic wall varied. Inflammatory infiltrates within the deep part of the intima, around areas of neovascularization and within the adventitia contained T-cells colocalizing with dendritic cells. Nodules formed by large numbers of intermingling T-cells and B-cells enriched with dendritic cells were observed in the adventitia. Massive accumulation of granulocytes and their destruction within the adventitia were prominent in all cases. This is the first study that establishes the presence of dendritic cells and granulocytes in Takayasu's disease. Dendritic cells are probably involved in the immunoinflammatory processes through their interaction with T-cells and B-cells. The present observations may help understanding of the pathogenesis of Takayasu's disease.

Entities:  

Mesh:

Year:  2000        PMID: 10917581     DOI: 10.1177/000331970005100705

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  11 in total

Review 1.  Takayasu's arteritis: a review of the literature.

Authors:  Silvia Maffei; Michela Di Renzo; Giovanni Bova; Alberto Auteri; Anna Laura Pasqui
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 2.  Dendritic cells and regulatory T cells in atherosclerosis.

Authors:  Cheolho Cheong; Jae-Hoon Choi
Journal:  Mol Cells       Date:  2012-06-28       Impact factor: 5.034

3.  Childhood-onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Marinka Twilt; Rae S M Yeung
Journal:  Eur J Rheumatol       Date:  2020-02

Review 4.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

5.  T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases.

Authors:  Andrew H Lichtman
Journal:  Front Physiol       Date:  2012-02-16       Impact factor: 4.566

Review 6.  An Update on Childhood-Onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Rae S M Yeung; Ronald M Laxer
Journal:  Front Pediatr       Date:  2022-04-13       Impact factor: 3.569

Review 7.  Role of Neutrophils in Systemic Vasculitides.

Authors:  Despina Michailidou; Tomas Mustelin; Christian Lood
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

Review 8.  Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.

Authors:  Haiyan Li; Zongwen Shuai
Journal:  Heart Vessels       Date:  2021-11-08       Impact factor: 2.037

9.  Tertiary Lymphoid Organs in Takayasu Arteritis.

Authors:  Marc Clement; Adrien Galy; Patrick Bruneval; Marion Morvan; Fabien Hyafil; Khadija Benali; Nicoletta Pasi; Lydia Deschamps; Quentin Pellenc; Thomas Papo; Antonino Nicoletti; Karim Sacre
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

Review 10.  Takayasu Arteritis.

Authors:  Ricardo A G Russo; María M Katsicas
Journal:  Front Pediatr       Date:  2018-09-24       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.